CDH23 Gene Deafness Autosomal Recessive Type 12 Genetic Test sale cost 4400 AED
DIAPH1 Gene Deafness Autosomal Dominant Type 1 Genetic Test sale cost 4400 AED DIAPH1 Gene Deafness Autosomal Dominant Type 1 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
RDX Gene Deafness Autosomal Recessive Type 24 Genetic Test sale cost 4400 AED RDX Gene Deafness Autosomal Recessive Type 24 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CDH23 Gene Deafness Autosomal Recessive Type 12 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CDH23 gene is associated with a form of deafness known as Autosomal Recessive Type 12. This condition is characterized by a mutation in the CDH23 gene, which plays a critical role in the structure and function of hair cells in the inner ear. These cells are essential for converting sound vibrations into electrical signals that the brain can interpret as sound. When mutations occur in the CDH23 gene, it can lead to significant hearing impairment or deafness from birth or early childhood.

To diagnose this specific type of genetic hearing loss, a genetic test targeting the CDH23 gene can be conducted. This test involves analyzing the DNA to identify mutations in the CDH23 gene that are known to cause Autosomal Recessive Type 12 deafness. The process typically requires a sample of blood or saliva from which DNA is extracted and then examined for the specific genetic changes.

In the UAE, DNA Labs offers this specialized genetic testing service. The cost of the CDH23 Gene Deafness Autosomal Recessive Type 12 Genetic Test at DNA Labs UAE is 4400 AED. This test is crucial for families with a history of hearing loss, as it can provide a definitive diagnosis of the condition. Moreover, understanding the genetic basis of the hearing loss can inform decisions about treatment and management, including the use of hearing aids, cochlear implants, and other interventions to support communication.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CDH23 Gene Deafness Autosomal Recessive Type 12 Genetic Test

Components

  • Test Name: CDH23 Gene Deafness Autosomal Recessive Type 12 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS7.

Test Details

The CDH23 gene is associated with a type of deafness known as autosomal recessive type 12 (DFNB12). This genetic condition is characterized by progressive hearing loss that typically begins in childhood or adolescence. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the context of CDH23 gene deafness, an NGS genetic test would involve sequencing the CDH23 gene to identify any genetic variations or mutations that may be causing or contributing to the individual’s hearing loss. The results of an NGS genetic test for CDH23 gene deafness can help in confirming a diagnosis, providing information about the specific genetic mutation causing the condition, and determining the inheritance pattern. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options or interventions for managing the hearing loss.

Test Name CDH23 Gene Deafness autosomal recessive type 12 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS7
Test Details

The CDH23 gene is associated with a type of deafness known as autosomal recessive type 12 (DFNB12). This genetic condition is characterized by progressive hearing loss that typically begins in childhood or adolescence.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the context of CDH23 gene deafness, an NGS genetic test would involve sequencing the CDH23 gene to identify any genetic variations or mutations that may be causing or contributing to the individual’s hearing loss.

The results of an NGS genetic test for CDH23 gene deafness can help in confirming a diagnosis, providing information about the specific genetic mutation causing the condition, and determining the inheritance pattern. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options or interventions for managing the hearing loss.

SKU: TEST-2702 Category:

Related products